Jia Jie Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 11, 2022 at 05:00 am EST
Share
Jia Jie Biomedical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 85.07 million compared to TWD 55.51 million a year ago. Net income was TWD 2.41 million compared to TWD 0.521 million a year ago. Basic earnings per share from continuing operations was TWD 0.03 compared to TWD 0.01 a year ago. Diluted earnings per share from continuing operations was TWD 0.03 compared to TWD 0.01 a year ago.
For the nine months, sales was TWD 230.45 million compared to TWD 160.72 million a year ago. Net loss was TWD 1.09 million compared to TWD 2.9 million a year ago. Basic loss per share from continuing operations was TWD 0.01 compared to TWD 0.03 a year ago. Diluted loss per share from continuing operations was TWD 0.01 compared to TWD 0.03 a year ago.
Jia Jie Biomedical Co Ltd is a Taiwan-based company mainly engaged in the processing, production and distribution of turtles and turtle processed products. The Company operates through two business segments. Taiwan Operation segment is engaged in the production and sale of health foods. China Mainland Operation segment is engaged in the production of water purification equipment and related parts. Products are include nutrition and health care series, health water series, home supplies series. Products are mainly sold to Taiwan and mainland China.
JIA JIE BIOMEDICAL CO., LTD. 
